甲状腺激素受体β1在甲状腺滤泡癌的预后价值

Value of thyroid hormone receptor β1 for the prognosis of follicular thyroid cancer

  • 摘要: 目的 探讨甲状腺激素受体β1(thyroid hormone receptor,TRβ1)在甲状腺滤泡癌组织中的表达及临床意义。 方法 用S-P免疫组化学方法检测54例甲状腺滤泡癌及45例滤泡性腺瘤组织中TRβ1表达情况,并查阅分析临床病理资料。 结果 甲状腺滤泡癌的阳性表达率为16.7%(9/54),甲状腺滤泡性腺瘤组织中表达率为71.1%(32/45),二者存在统计学差异(P<0.01);在甲状腺滤泡癌患者中,TRβ1的表达因临床分期(P=0.010)、淋巴结转移(P=0.036)、远处转移(P=0.028)和肿瘤大小(P=0.048)而不同,差异具有统计学意义。 结论 TRβ1在甲状腺滤泡癌中显著低表达,而在甲状腺滤泡性腺瘤高表达;TRβ1的表达与肿瘤大小、临床分期、淋巴结转移和远处转移相关,对病人预后有提示作用。

     

    Abstract: Objective To study the expression of thyroid hormone receptor β1(TRβ1) in follicular thyroid carcinoma and adenoma and its clinical significance. Methods Expressions of TRβ1 in 54 follicular thyroid carcinoma patients and 45 follicular thyroid adenoma patients were detected by S-P immunohistochemistry.Clinicopathological data about the patients were analyzed. Results The positive expression rate of TRβ1 was significantly lower in follicular thyroid carcinoma than in follicular thyroid adenoma(16.7% vs 71.1%,P<0.01).The TRβ1 expression was significantly different in follicular thyroid carcinoma and adenoma due to their different TNM stage,size,lymph node metastasis,and distant metastasis(P<0.05). Conclusion TRβ1 is lowly expressed in follicular thyroid carcinoma and highly expressed in follicular thyroid adenoma,indicating that TRβ1 plays an important role in the pathogenesis of follicular thyroid carcinoma.TRβ1 expression is related with the size,lymph node metastasis,distant metastasis and TNM stage of follicular thyroid carcinoma,and can thus predict the prognosis of such patients.

     

/

返回文章
返回